PATENT CLAIM ANALYSIS

Application Number: 15963173
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "144100"]

Abstract:
Highly effective vaccine compositions are constructed according to the methods of this invention. The methods are amenable to use with any peptidic antigen sequence and involve covalent attachment of an immunostimulatory nucleotide sequence to an antigenic peptide sequence. Preferred antigenic peptides are fusion peptides made up of one or more CTL epitope peptides in sequence fused to a T helper peptide.

Claim (Index 16):
The molecule of  claim 9 , wherein fusion peptide is synthetic.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 91.0
- Lexical Diversity: 1.3913
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14736897', '11008958', '14162600', '10076674', '13294006']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7631736675404989
- 35 USC 102 Novelty (BERT): 0.6106407301843289
- Combined Prediction Score: 0.7479203738048819
- Mean Citation Score: 461.475504
- Max Citation Score: 716.69006
- Similarity Product: 459.7256574470687

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test